tiprankstipranks
Advertisement
Advertisement

BCRX Stock Latest News

BioCryst price target raised to $14 from $13 at RBC Capital
The FlyBioCryst price target raised to $14 from $13 at RBC Capital
1d ago
BCRX
BioCryst appoints Sandeep Menon as chief research and development officer
PremiumThe Fly
BioCryst appoints Sandeep Menon as chief research and development officer
2d ago
ALNY
BCRX
EOG, GitLab, StoneCo, Cipher, BioCryst Insider Shake-Up
PremiumWeekend Updates
EOG, GitLab, StoneCo, Cipher, BioCryst Insider Shake-Up
11d ago
EOG
BCRX
3 Best Value Stocks with Over 20% Upside in 2026, According to Analysts 
PremiumMarket News
3 Best Value Stocks with Over 20% Upside in 2026, According to Analysts 
22d ago
DOX
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
1M ago
BCRX
BioCryst price target raised to $22 from $21 at Wedbush
PremiumThe FlyBioCryst price target raised to $22 from $21 at Wedbush
1M ago
BCRX
Brand Risks Emerge in BioCryst’s ORLADEYO Sale to Neopharmed as Fragmented Positioning Threatens Long‑Term Value
Premium
Company Announcements
Brand Risks Emerge in BioCryst’s ORLADEYO Sale to Neopharmed as Fragmented Positioning Threatens Long‑Term Value
1M ago
BCRX
BioCryst Earnings Call Highlights Profits, Pipeline Momentum
Premium
Company Announcements
BioCryst Earnings Call Highlights Profits, Pipeline Momentum
1M ago
BCRX
BioCryst Boosts HAE Franchise With Astria Acquisition, Guidance
PremiumCompany Announcements
BioCryst Boosts HAE Franchise With Astria Acquisition, Guidance
1M ago
8K
BCRX
BioCryst reports Q4 EPS $1.12 vs (13c) last year
PremiumThe Fly
BioCryst reports Q4 EPS $1.12 vs (13c) last year
1M ago
BCRX
BioCryst sees FY26 revenue $635M-$660M, consensus $657.1M
PremiumThe Fly
BioCryst sees FY26 revenue $635M-$660M, consensus $657.1M
1M ago
BCRX
Is BCRX a Buy, Before Earnings?
PremiumPre-Earnings
Is BCRX a Buy, Before Earnings?
1M ago
BCRX
BioCryst resumed with an Outperform at Evercore ISI
PremiumThe FlyBioCryst resumed with an Outperform at Evercore ISI
2M ago
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
Premium
The Fly
BioCryst reports inducement grants under Nasdaq listing rule
2M ago
BCRX
BioCryst Closes Blackstone Loan and Astria Acquisition
Premium
Company Announcements
BioCryst Closes Blackstone Loan and Astria Acquisition
2M ago
8K
BCRX
BioCryst completes acquisition of Astria Therapeutics
PremiumThe Fly
BioCryst completes acquisition of Astria Therapeutics
3M ago
ATXS
BCRX
Astria stockholders vote to approve acquisition by BioCryst
PremiumThe Fly
Astria stockholders vote to approve acquisition by BioCryst
3M ago
ATXS
BCRX
BioCryst: Sustained Orladeyo Momentum, Disciplined Financials, and Pipeline Upside Support Buy Rating
PremiumRatings
BioCryst: Sustained Orladeyo Momentum, Disciplined Financials, and Pipeline Upside Support Buy Rating
3M ago
BCRX
BioCryst Updates ORLADEYO Revenue Outlook and Guidance
PremiumCompany Announcements
BioCryst Updates ORLADEYO Revenue Outlook and Guidance
3M ago
8K
BCRX
BioCryst reports preliminary Q4 ORLADEYO revenue $151M
PremiumThe FlyBioCryst reports preliminary Q4 ORLADEYO revenue $151M
3M ago
BCRX
BioCryst sees FY26 revenue $635M-$660M
Premium
The Fly
BioCryst sees FY26 revenue $635M-$660M
3M ago
BCRX
BioCryst Raises Price of Key ORLADEYO Treatment
Premium
Company Announcements
BioCryst Raises Price of Key ORLADEYO Treatment
3M ago
8K
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >